FDA — authorised 24 March 2023
- Application: NDA217759
- Marketing authorisation holder: PHARMING
- Local brand name: JOENJA
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Joenja in United States
FDA authorised Joenja on 24 March 2023
Marketing authorisation
Joenja in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Joenja approved in United States?
Yes. FDA authorised it on 24 March 2023.
Who is the marketing authorisation holder for Joenja in United States?
PHARMING holds the US marketing authorisation.